PELOSI, NANCY BUYNVDA$500K–$1M—·TUBERVILLE, TOMMY BUYMSFT$50K–$100K—·CRENSHAW, DAN SELLXOM$15K–$50K—·PELOSI, NANCY BUYNVDA$500K–$1M—·TUBERVILLE, TOMMY BUYMSFT$50K–$100K—·CRENSHAW, DAN SELLXOM$15K–$50K—·
K-STREET TRACKER

FOLLOW THE MONEY INTO THE SWAMP

Every federal lobbying filing tagged with a public-company ticker — who is spending, which firms they hire, and which members trade right around the filing.

Filings tracked
19,882
thru 2026-05-08
Total reported $
$2.7B
disclosed lobbying
Distinct clients
2,220
paying companies
Tickers targeted
1,207
public companies

💸 Top Spending Clients

#ClientFilingsTotal $
1PFIZER INC.PFE47$46.8M
2GENERAL MOTORS COMPANYGM61$46.8M
3META PLATFORMS INC. AND VARIOUS SUBSIDIARIESMETA12$44.9M
4VISA INC.V45$37.7M
5AMAZON.COM SERVICES LLCAMZN36$32.8M
6LOCKHEED MARTIN CORPORATIONLMT73$29.0M
7FEDEX CORPORATIONFDX69$27.8M
8ELI LILLY AND COMPANYLLY56$27.1M
9ALTRIA CLIENT SERVICES LLCMO142$25.2M
10AMGEN INCAMGN19$24.9M
11COMCAST CORPORATIONCMCSV179$24.7M
12MERCK & CO INCMRK14$24.0M
13SOUTHERN COMPANYSO53$23.9M
14GOOGLE CLIENT SERVICES LLCGOOGL79$22.6M
15APPLE INCAAPL9$22.1M
16T-MOBILE USA INC.TMUS121$21.0M
17UNITEDHEALTH GROUP INCUNH19$20.4M
18VERIZON COMMUNICATIONS INC AND VARIOUS SUBSIDIARIESVZ40$20.1M
19OCCIDENTAL PETROLEUM CORPORATIONOXY30$19.7M
20MICROSOFT CORPORATIONMSFT103$18.8M
21QUALCOMM INCORPORATEDQCOM40$17.2M
22GENERAL DYNAMICS CORPGD11$17.0M
23BOEING COMPANYBA23$16.9M
24THE CIGNA GROUP AND SUBSIDIARIES (FORMERLY CIGNA CORPORATION AND SUBSIDIARIES)CI13$16.9M
25ORACLE CORPORATIONORCL58$16.7M

🎯 Top Lobbied Tickers

#TickerFilingsTotal $
1META
Meta Platforms Inc.
129$50.2M
2PFE
Pfizer Inc.
87$48.6M
3GM
General Motors Company
103$48.4M
4V
Visa Inc.
46$37.7M
5AMZN
Amazon.com Inc.
80$35.3M
6LMT
Lockheed Martin Corporation
88$29.4M
7FDX
FedEx Corporation
82$28.3M
8LLY
Eli Lilly and Company
83$28.1M
9AMGN
Amgen Inc.
95$28.0M
10MRK
Merck & Co. Inc.
92$27.5M
11AAPL
Apple Inc.
64$26.8M
12GOOGL
Alphabet Inc. Class A
123$26.6M
13MO164$26.2M
14SO
Southern Company
108$26.1M
15UNH
UnitedHealth Group Inc.
67$23.9M
16VZ
Verizon Communications Inc.
116$23.8M
17TMUS159$22.7M
18CHTR137$22.6M
19GD
General Dynamics Corporation
127$22.5M
20T
AT&T Inc.
134$21.6M
21ORCL
Oracle Corporation
132$20.6M
22CMCSA
Comcast Corporation
141$20.4M
23CI
The Cigna Group
64$19.9M
24OXY
Occidental Petroleum Corporation
36$19.9M
25MSFT
Microsoft Corporation
122$19.2M

🆕 Filtered Filings · VERTEX PHARMACEUTICALS

clear filters
DateTickerClientRegistrantAmountIssue
2026-04-19VRTXVERTEX PHARMACEUTICALSTIBER CREEK GROUP$60KIssues related to drug pricing; Issues related to H.R. 1227/S. 475 - Alternatives to PAIN Act; Issues related to H.R. 1518 - New Era of Preventing End-Stage Kidney Disease Act. Issues related to coverage of opioid alternatives.
2026-04-17VRTXVERTEX PHARMACEUTICALSSALT POINT STRATEGIES$10KNon-opioid pain relief and drug pipeline issues.
2026-04-15VRTXVERTEX PHARMACEUTICALSALB SOLUTIONS$50KNon-opioid pain relief and drug pipeline issues.
2026-03-10VRTXVERTEX PHARMACEUTICALSALB SOLUTIONS$0Non-opioid pain relief and drug pipeline issues.
2026-01-18VRTXVERTEX PHARMACEUTICALSSALT POINT STRATEGIES$40KNon-opioid pain relief and drug pipeline issues.
2026-01-17VRTXVERTEX PHARMACEUTICALSTIBER CREEK GROUP$60KIssues related to drug pricing; Issues related to H.R. 1227/S. 475 - Alternatives to PAIN Act. Issues related to opioid alternatives; Issues related to the National Defense Authorization Act for Fiscal Year 2026 (PL 119-60).
2025-10-20VRTXVERTEX PHARMACEUTICALSSALT POINT STRATEGIES$30KNon-opioid pain relief and drug pipeline issues.
2025-10-19VRTXVERTEX PHARMACEUTICALSTIBER CREEK GROUP$60KIssues related to drug pricing; Issues related to H.R. 1227/S. 475 - Alternatives to PAIN Act. Issues related to opioid alternatives; Issues related to H.R. 3838 - Streamlining Procurement for Effective Execution and Delivery and National Defense Authorization Act for Fiscal Year 2026; Issues related to S. 2296 - National Defense Authorization Act for Fiscal Year 2026.
2025-07-21VRTXVERTEX PHARMACEUTICALSTIBER CREEK GROUP$80KIssues related to drug pricing; Issues related to H.R. 1227/S. 475 - Alternatives to Prevent Addiction in the Nation (Alternatives to PAIN) Act. Issues related to opioid alternatives; Issues related to H.R. 3838 - SPEED Act; Issues related to S. 2296 - National Defense Authorization Act for Fiscal Year 2026.
2025-07-16VRTXVERTEX PHARMACEUTICALSSALT POINT STRATEGIES$30KNon-opioid pain relief and drug pipeline issues.
2025-04-19VRTXVERTEX PHARMACEUTICALSTIBER CREEK GROUP$80KIssues related to drug pricing; Issues related to H.R. 7142/S. 3832 - Alternatives to Prevent Addiction in the Nation (Alternatives to PAIN) Act. Issues related to opioid alternatives.
2025-04-19VRTXVERTEX PHARMACEUTICALSSALT POINT STRATEGIES$30KNon-opioid pain relief and drug pipeline issues.
2025-02-24VRTXVERTEX PHARMACEUTICALSSALT POINT STRATEGIES$0Non-opioid pain relief and drug pipeline issues.
2025-01-19VRTXVERTEX PHARMACEUTICALSTIBER CREEK GROUP$80KIssues related to drug pricing; Issues related to H.R.7142/S.3832 - Alternatives to Prevent Addiction in the Nation (Alternatives to PAIN) Act.